Ana Saez-Benito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Saez-Benito has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso Maria Lechuga-Sancho
Servicio de Pediatría, Hospital Universitario Puerta del Mar, Cádiz, Spain
5 shared publications - Francisco Visiedo
Inflammation and Metabolic Syndrome in Pregnancy Group (CO25), Biomedical Research and Innovation Institute of Cádiz (INiBICA), 11009 Cádiz, Spain
5 shared publications - Rosa María Mateos
Research Unit, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Puerta del Mar University Hospital, 11009 Cadiz, Spain
5 shared publications - Felix A. Ruiz
Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain
3 shared publications - Germán Perdomo
Instituto de Biomedicina y Genética Molecular (Consejo Superior de Investigaciones Científicas-Universidad de Valladolid), 47003 Valladolid, Spain
3 shared publications - Fernando Bugatto
Area of Obstetrics and Gynaecology, Department of Child and Mother Health and Radiology, School of Medicine, University of Cádiz, 11009 Cádiz, Spain
2 shared publications
Latest Publications
- Open Access
- 21 November 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (12) , 1694
Plasma Inorganic Polyphosphate Is Associated with Gestational Diabetes Mellitus in Early Pregnancy: Evidence from Two Independent Cross-Sectional Populations
Plasma inorganic polyphosphate (polyP) is a biologically active phosphate polymer implicated in coagulation, inflammation, and cellular metabolism. However, circulating polyP has not been well characterized during pregnancy, and its relationship with gestational diabetes mellitus (GDM) remains unclear. Here, we evaluated plasma polyP concentrations in two independent retrospective cross-sectional cohorts of pregnant women studied during the first and third trimesters. A total of 101 women were included: 40 in the first-trimester cohort and 61 in the third-trimester cohort. Plasma polyP was quantified specifically using an enzymatic assay based on recombinant Saccharomyces cerevisiae exopolyphosphatase and normalized to protein content. PolyP concentrations were higher in the first-trimester cohort than in the third-trimester cohort. Within the first-trimester cohort, women with GDM had significantly higher polyP concentrations than women without GDM. In the third-trimester cohort, women with GDM had significantly lower polyP concentrations than controls. Exploratory receiver operating characteristic (ROC) analyses suggested a potential discriminatory signal of plasma polyP concentrations in relation to GDM status in both cohorts. Overall, the findings indicate that circulating polyP concentrations vary according to gestational stage and GDM status. Prospective longitudinal studies with larger, independently validated cohorts are needed to determine the temporal behavior, biological determinants, and potential clinical relevance of circulating polyP during pregnancy.
- 21 November 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (12) , 1694
Open AccessPlasma Inorganic Polyphosphate Is Associated with Gestational Diabetes Mellitus in Early Pregnancy: Evidence from Two Independent Cross-Sectional Populations
Plasma inorganic polyphosphate (polyP) is a biologically active phosphate polymer implicated in coagulation, inflammation, and cellular metabolism. However, circulating polyP has not been well characterized during pregnancy, and its relationship with gestational diabetes mellitus (GDM) remains unclear. Here, we evaluated plasma polyP concentrations in two independent retrospective cross-sectional cohorts of pregnant women studied during the first and third trimesters. A total of 101 women were included: 40 in the first-trimester cohort and 61 in the third-trimester cohort. Plasma polyP was quantified specifically using an enzymatic assay based on recombinant Saccharomyces cerevisiae exopolyphosphatase and normalized to protein content. PolyP concentrations were higher in the first-trimester cohort than in the third-trimester cohort. Within the first-trimester cohort, women with GDM had significantly higher polyP concentrations than women without GDM. In the third-trimester cohort, women with GDM had significantly lower polyP concentrations than controls. Exploratory receiver operating characteristic (ROC) analyses suggested a potential discriminatory signal of plasma polyP concentrations in relation to GDM status in both cohorts. Overall, the findings indicate that circulating polyP concentrations vary according to gestational stage and GDM status. Prospective longitudinal studies with larger, independently validated cohorts are needed to determine the temporal behavior, biological determinants, and potential clinical relevance of circulating polyP during pregnancy.
- Open Access
Proinflammatory Polyphosphate Increases in Plasma of Obese Children with Insulin Resistance and Adults with Severe Type 2 Diabetes
Obesity increases the risk of insulin resistance and type 2 diabetes through increased inflammation at cellular and tissue levels. Therefore, study of the molecular elements involved in obesity-related inflammation may contribute to preventing and controlling it. Inorganic polyphosphate is a natural phosphate polymer that has recently been attracting more attention for its role in inflammation and hemostasis processes. Polyphosphates are one of the main constituents of human platelets, which are secreted after platelet activation. Among other roles, they interact with multiple proteins of the coagulation cascade, trigger bradykinin release, and inhibit the complement system. Despite its importance, determinations of polyphosphate levels in blood plasma had been elusive until recently, when we developed a method to detect these levels precisely. Here, we perform cross sectional studies to evaluate plasma polyphosphate in: 25 children, most of them with obesity and overweight, and 20 adults, half of them with severe type 2 diabetes. Our results show that polyphosphate increases, in a significant manner, in children with insulin resistance and in type 2 diabetes patients. As we demonstrated before that polyphosphate decreases in healthy overweight individuals, these results suggest that this polymer could be an inflammation biomarker in the metabolic disease onset before diabetes.
Open AccessProinflammatory Polyphosphate Increases in Plasma of Obese Children with Insulin Resistance and Adults with Severe Type 2 Diabetes
Obesity increases the risk of insulin resistance and type 2 diabetes through increased inflammation at cellular and tissue levels. Therefore, study of the molecular elements involved in obesity-related inflammation may contribute to preventing and controlling it. Inorganic polyphosphate is a natural phosphate polymer that has recently been attracting more attention for its role in inflammation and hemostasis processes. Polyphosphates are one of the main constituents of human platelets, which are secreted after platelet activation. Among other roles, they interact with multiple proteins of the coagulation cascade, trigger bradykinin release, and inhibit the complement system. Despite its importance, determinations of polyphosphate levels in blood plasma had been elusive until recently, when we developed a method to detect these levels precisely. Here, we perform cross sectional studies to evaluate plasma polyphosphate in: 25 children, most of them with obesity and overweight, and 20 adults, half of them with severe type 2 diabetes. Our results show that polyphosphate increases, in a significant manner, in children with insulin resistance and in type 2 diabetes patients. As we demonstrated before that polyphosphate decreases in healthy overweight individuals, these results suggest that this polymer could be an inflammation biomarker in the metabolic disease onset before diabetes.
- Open Access
- 28 August 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 191, 40-47
Catalase post-translational modifications as key targets in the control of erythrocyte redox homeostasis in children with obesity and insulin resistance
- 28 August 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 191, 40-47
Open AccessCatalase post-translational modifications as key targets in the control of erythrocyte redox homeostasis in children with obesity and insulin resistance
- Open Access
- 5 February 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (2) , 244
Blunted Reducing Power Generation in Erythrocytes Contributes to Oxidative Stress in Prepubertal Obese Children with Insulin Resistance
Childhood obesity, and specifically its metabolic complications, are related to deficient antioxidant capacity and oxidative stress. Erythrocytes are constantly exposed to multiple sources of oxidative stress; hence, they are equipped with powerful antioxidant mechanisms requiring permanent reducing power generation and turnover. Glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGDH) are two key enzymes on the pentose phosphate pathway. Both enzymes supply reducing power by generating NADPH, which is essential for maintaining the redox balance within the cell and the activity of other antioxidant enzymes. We hypothesized that obese children with insulin resistance would exhibit blunted G6PDH and 6PGDH activities, contributing to their erythrocytes’ redox status imbalances. We studied 15 control and 24 obese prepubertal children, 12 of whom were insulin-resistant according to an oral glucose tolerance test (OGTT). We analyzed erythroid malondialdehyde (MDA) and carbonyl group levels as oxidative stress markers. NADP+/NADPH and GSH/GSSG were measured to determine redox status, and NADPH production by both G6PDH and 6PGDH was assayed spectrophotometrically to characterize pentose phosphate pathway activity. Finally, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and glutathione reductase (GR) activities were also assessed. As expected, MDA and carbonyl groups levels were higher at baseline and along the OGTT in insulin-resistant children. Both redox indicators showed an imbalance in favor of the oxidized forms along the OGTT in the insulin-resistant obese group. Additionally, the NADPH synthesis, as well as GR activity, were decreased. H2O2 removing enzyme activities were depleted at baseline in both obese groups, although after sugar intake only metabolically healthy obese participants were able to maintain their catalase activity. No change was detected in SOD activity between groups. Our results show that obese children with insulin resistance present higher levels of oxidative damage, blunted capacity to generate reducing power, and hampered function of key NADPH-dependent antioxidant enzymes.
- 5 February 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (2) , 244
Open AccessBlunted Reducing Power Generation in Erythrocytes Contributes to Oxidative Stress in Prepubertal Obese Children with Insulin Resistance
Childhood obesity, and specifically its metabolic complications, are related to deficient antioxidant capacity and oxidative stress. Erythrocytes are constantly exposed to multiple sources of oxidative stress; hence, they are equipped with powerful antioxidant mechanisms requiring permanent reducing power generation and turnover. Glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGDH) are two key enzymes on the pentose phosphate pathway. Both enzymes supply reducing power by generating NADPH, which is essential for maintaining the redox balance within the cell and the activity of other antioxidant enzymes. We hypothesized that obese children with insulin resistance would exhibit blunted G6PDH and 6PGDH activities, contributing to their erythrocytes’ redox status imbalances. We studied 15 control and 24 obese prepubertal children, 12 of whom were insulin-resistant according to an oral glucose tolerance test (OGTT). We analyzed erythroid malondialdehyde (MDA) and carbonyl group levels as oxidative stress markers. NADP+/NADPH and GSH/GSSG were measured to determine redox status, and NADPH production by both G6PDH and 6PGDH was assayed spectrophotometrically to characterize pentose phosphate pathway activity. Finally, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and glutathione reductase (GR) activities were also assessed. As expected, MDA and carbonyl groups levels were higher at baseline and along the OGTT in insulin-resistant children. Both redox indicators showed an imbalance in favor of the oxidized forms along the OGTT in the insulin-resistant obese group. Additionally, the NADPH synthesis, as well as GR activity, were decreased. H2O2 removing enzyme activities were depleted at baseline in both obese groups, although after sugar intake only metabolically healthy obese participants were able to maintain their catalase activity. No change was detected in SOD activity between groups. Our results show that obese children with insulin resistance present higher levels of oxidative damage, blunted capacity to generate reducing power, and hampered function of key NADPH-dependent antioxidant enzymes.
- Open Access
- 20 May 2018
- Published by Elsevier in Atencion Primaria
- Vol. 51 (2) , 118-120
Reflexiones sobre «Visión crítica y argumentación sobre los programas de atención de la cronicidad en Atención Primaria y Comunitaria»
- 20 May 2018
- Published by Elsevier in Atencion Primaria
- Vol. 51 (2) , 118-120
Open AccessReflexiones sobre «Visión crítica y argumentación sobre los programas de atención de la cronicidad en Atención Primaria y Comunitaria»
- 1 March 2018
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 65 (3) , 150-155
Impacto de la autoinmunidad antitiroidea positiva en gestantes con hipotiroidismo subclínico
- 1 March 2018
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 65 (3) , 150-155
Impacto de la autoinmunidad antitiroidea positiva en gestantes con hipotiroidismo subclínico
- Open Access
- 25 January 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (1) , e0191547
Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age
Oxidative stress and inflammation have been postulated as underlying mechanisms for the development of obesity-related insulin resistance. This association however, remains elusive especially in childhood. We sought to investigate this relation by measuring oxidative stress and antioxidant response biomarkers, before and during an oral glucose tolerance test (OGTT), in different biological samples from obese children. 24 children were recruited for the study, (18 obese and 6 controls). After OGTT, the obese group was subdivided in two, according to whether or not carbohydrate metabolic impairment (Ob.IR+, Ob.IR-; respectively) was found. Different biomarkers were analyzed after fasting (T = 0) and during an OGTT (T = 60 and 120 min). Lipoperoxides were measured in plasma, erythrocytes, and urine; while advanced glycation end products were determined in plasma, and redox status (GSH/GSSG ratio) in erythrocytes. We found marked differences in the characterization of the oxidative status in urine and erythrocytes, and in the dynamics of the antioxidant response during OGTT. Specifically, Ob.IR+ children show increased oxidative stress, deficient antioxidant response and a significant imbalance in redox status, in comparison to controls and Ob.IR- children. Obese children with insulin resistance show increased levels of oxidative stress biomarkers, and a stunted antioxidant response to an OGTT leading to increased oxidative stress after a single glucose load, as detected in erythrocytes, but not in plasma. We propose erythrocytes as sensors of early and acute changes in oxidative stress associated with insulin resistance in childhood obesity. This is a pilot study, performed with a limited sample size, so data should be interpreted with caution until reproduced.
- 25 January 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (1) , e0191547
Open AccessObesity induced alterations in redox homeostasis and oxidative stress are present from an early age
Oxidative stress and inflammation have been postulated as underlying mechanisms for the development of obesity-related insulin resistance. This association however, remains elusive especially in childhood. We sought to investigate this relation by measuring oxidative stress and antioxidant response biomarkers, before and during an oral glucose tolerance test (OGTT), in different biological samples from obese children. 24 children were recruited for the study, (18 obese and 6 controls). After OGTT, the obese group was subdivided in two, according to whether or not carbohydrate metabolic impairment (Ob.IR+, Ob.IR-; respectively) was found. Different biomarkers were analyzed after fasting (T = 0) and during an OGTT (T = 60 and 120 min). Lipoperoxides were measured in plasma, erythrocytes, and urine; while advanced glycation end products were determined in plasma, and redox status (GSH/GSSG ratio) in erythrocytes. We found marked differences in the characterization of the oxidative status in urine and erythrocytes, and in the dynamics of the antioxidant response during OGTT. Specifically, Ob.IR+ children show increased oxidative stress, deficient antioxidant response and a significant imbalance in redox status, in comparison to controls and Ob.IR- children. Obese children with insulin resistance show increased levels of oxidative stress biomarkers, and a stunted antioxidant response to an OGTT leading to increased oxidative stress after a single glucose load, as detected in erythrocytes, but not in plasma. We propose erythrocytes as sensors of early and acute changes in oxidative stress associated with insulin resistance in childhood obesity. This is a pilot study, performed with a limited sample size, so data should be interpreted with caution until reproduced.
- 1 August 2014
- Published by Elsevier in Clinical Biochemistry
- Vol. 47 (12) , 1108-1111
Multicentre evaluation of glycated haemoglobin (HbA1c) of Roche Diagnostics in Andalusia
- 1 August 2014
- Published by Elsevier in Clinical Biochemistry
- Vol. 47 (12) , 1108-1111
Multicentre evaluation of glycated haemoglobin (HbA1c) of Roche Diagnostics in Andalusia
- 1 January 2013
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 26 (7-8) , 709-714
Hepatocyte growth factor as an indicator of neonatal maturity
Hepatocyte growth factor (HGF) is a potent mitogen and morphogen expressed in fetal organs. It requires activation by specific serine proteases. The role of activated HGF during fetal development has not been evaluated. We hypothesized that the serum levels of activated HGF would be increased in preterm neonates. Cord blood total HGF and activated HGF levels were measured in 19 preterm (gestational age, 28.04±2.39 weeks) and 24 term (gestational age, 39.37±0.95 weeks) newborns. Anthropometric parameters and metabolic indices were evaluated. Activated HGF was higher in preterm than in term neonates (0.81±0.05 vs. 0.61±0.06 ng/mL, p<0.05), whereas total HGF levels did not differ significantly between groups. In addition, total and activated HGF further increased by ∼40% in preterm neonates 12 h after birth. Finally, activated HGF correlated inversely with gestational age (r=-0.369; p=0.015) and birth weight (r=-0.440; p=0.003). Our study demonstrates that regulation of HGF activity and circulating HGF levels differ between term and preterm neonates along fetal development.
- 1 January 2013
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 26 (7-8) , 709-714
Hepatocyte growth factor as an indicator of neonatal maturity
Hepatocyte growth factor (HGF) is a potent mitogen and morphogen expressed in fetal organs. It requires activation by specific serine proteases. The role of activated HGF during fetal development has not been evaluated. We hypothesized that the serum levels of activated HGF would be increased in preterm neonates. Cord blood total HGF and activated HGF levels were measured in 19 preterm (gestational age, 28.04±2.39 weeks) and 24 term (gestational age, 39.37±0.95 weeks) newborns. Anthropometric parameters and metabolic indices were evaluated. Activated HGF was higher in preterm than in term neonates (0.81±0.05 vs. 0.61±0.06 ng/mL, p<0.05), whereas total HGF levels did not differ significantly between groups. In addition, total and activated HGF further increased by ∼40% in preterm neonates 12 h after birth. Finally, activated HGF correlated inversely with gestational age (r=-0.369; p=0.015) and birth weight (r=-0.440; p=0.003). Our study demonstrates that regulation of HGF activity and circulating HGF levels differ between term and preterm neonates along fetal development.